WALNUT CREEK,Calif.--The US Department of Energy's Joint Genome Institute has purchased an additional 60 MegaBace 1000 high-throughput DNA sequencers from Amersham Pharmacia Biotech, Nycomed Amersham's life science business. This acquisition brings the number of MegaBace sequencers in operation at the institute to 86. Trevor Hawkins, the institute's director of sequencing, said, "Since our initial order was installed in June, we have been extremely impressed with the results and performance of MegaBace."

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.